Pathological and biochemical outcomes after radical prostatectomy in men with low‐risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteriaKoji Mitsuzuka, Yoichi Arai, Chikara Οhyama et al.|British Journal of Urology|2013Cited by 49
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTakuma Narita, Chikara Οhyama, Koji Mitsuzuka et al.|Medical Oncology|2016Cited by 49
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomyTakuya Koie, Yuki Tobisawa, Shintaro Narita et al.|International Journal of Clinical Oncology|2014Cited by 40
Clinical implications of serum <i>N‐</i>glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumorsTakuma Narita, Chikara Οhyama, Tomonori Habuchi et al.|Cancer Medicine|2017Cited by 26
Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched AnalysisShintaro Narita, Tomonori Habuchi, Taketoshi Nara et al.|Clinical Genitourinary Cancer|2018Cited by 24